Â鶹´«Ã½Ó³»­

Â鶹´«Ã½Ó³»­

Explore the latest content from across our publications
Join The Â鶹´«Ã½Ó³»­

Log In

Forgot Password?
Create New Account

Loading... please wait

2009 Annual Meeting | E/M: Minimize Mistakes, Maximize Reimbursement

Wednesday 04/29/09
12:00 PM - 01:30 PM Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Luncheon Seminar
Marc R. Nuwer, MD, PhD, FÂ鶹´«Ã½Ó³»­
Participants should be able to appropriately code patient visits and be much more confident in coding and billing for complex services.
No CME available
Professionalism, Systems-based Practice
Introductory
Practitioner, Fellow, Academician, Resident
Event Timeline
12:00 PM - 12:30 PM E/M Part 1
Marc R. Nuwer, MD, PhD, FÂ鶹´«Ã½Ó³»­
12:00 PM - 01:30 PM Lunch
12:30 PM - 01:00 PM E/M Part 2
Jerzy P. Szaflarski, MD, PhD, FÂ鶹´«Ã½Ó³»­
01:00 PM - 01:30 PM Questions and Answers
Faculty Disclosures
Marc R. Nuwer, MD, PhD, FÂ鶹´«Ã½Ó³»­ Dr. Nuwer has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Several law firms. Dr. Nuwer has received publishing royalties from a publication relating to health care.
Jerzy P. Szaflarski, MD, PhD, FÂ鶹´«Ã½Ó³»­ Dr. Szaflarski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB Pharma. Dr. Szaflarski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for LivaNova Inc. Dr. Szaflarski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PureTech Health. Dr. Szaflarski has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Gidley, Sarli & Marusak, LLP. Dr. Szaflarski has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Szaflarski has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Law Firm. Dr. Szaflarski has stock in AdCel Biopharma, LLC. Dr. Szaflarski has stock in iFovea.